In June 2019, WHO announced the revision of two pain management guidelines. A public hearing regarding the scope of the guideline on ensuring balanced national policies for access and safe use of controlled medicines is scheduled for 19 February 2020 at 14:00 Geneva local time. Registrations to submit written comments and present oral statements at the hearing are due by 23:59 Geneva local time Tuesday 11 February 2020.
For all details, please visit this page.